6 patents
Utility
Genetically engineered hematopoietic stem cells and uses thereof
7 Feb 23
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Joseph Bolen, Aleksandar Filip Radovic-Moreno, John Lydeard
Filed: 5 Apr 21
Utility
Genetically engineered hematopoietic stem cells and uses thereof
24 Jan 23
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Joseph Bolen, Aleksandar Filip Radovic-Moreno, John Lydeard
Filed: 5 Apr 21
Utility
Genetically engineered hematopoietic stem cells and uses thereof
11 Oct 22
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Joseph Bolen, Aleksandar Filip Radovic-Moreno, John Lydeard
Filed: 5 Apr 21
Utility
Genetically engineered hematopoietic stem cells and uses thereof
19 Jul 22
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Joseph Bolen, Aleksandar Filip Radovic-Moreno, John Lydeard
Filed: 28 Aug 19
Utility
Genetically engineered hematopoietic stem cells and uses thereof
12 Jul 22
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Joseph Bolen, Aleksandar Filip Radovic-Moreno, John Lydeard
Filed: 5 Apr 21
Utility
Genetically engineered hematopoietic stem cells and uses thereof
23 Feb 21
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Joseph Bolen, Aleksandar Filip Radovic-Moreno, John Lydeard
Filed: 3 Dec 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first